Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2008 Mar 7;367(2):235-41.
doi: 10.1016/j.bbrc.2007.11.151. Epub 2007 Dec 4.

Twist is a transcriptional repressor of E-cadherin gene expression in breast cancer

Farhad Vesuna  1 , Paul van Diest, Ji Hshiung Chen, Venu Raman
Affiliations

Twist is a transcriptional repressor of E-cadherin gene expression in breast cancer

Farhad Vesuna et al. Biochem Biophys Res Commun. .

Abstract

Twist is a basic helix loop helix protein that plays a role both in human development and in cancer biogenesis. While characterizing the effects of Twist on breast epithelial cell transformation, we identified E-cadherin as a target gene that is down-regulated by Twist. In this study, we demonstrate that Twist can transcriptionally repress E-cadherin in breast cancer cells. Using transient promoter assays, we show that Twist can down-regulate E-cadherin promoter activity by up to two folds. This is further supported by immunoblot analyses which indicates that over-expression of Twist decreases E-cadherin protein levels in breast cancer cell lines. Subsequently, chromatin immunoprecipitation performed on MCF-7/Twist and Hs578 T (high level of endogenous Twist expression) confirmed Twist binding to the E-cadherin promoter. Finally, the functional relevance of this regulation was verified by quantitative real-time PCR and immunohistochemistry on a cohort of breast cancer samples.

PubMed Disclaimer

Figures

Figure 1
Figure 1. Twist inversely correlates with E-cadherin expression in breast cancer cells
A, Quantitative real-time PCR of breast cancer cell lines. Relative expression is calculated with MCF-7 as baseline. An inverse correlation was observed between Twist and E-cadherin mRNA expression as demonstrated by quantitative real-time PCR. B, Immunoblots showing E-cadherin and Twist expression in a panel of normal breast and breast cancer cell lines, which include both invasive and non-invasive phenotypes. Normal cell lines are seen on the left with progressively more invasive cell lines on the right. Antibodies against Twist were made in-house while E-cadherin (BD Biosciences) and β-actin (Sigma-Aldrich) were commercially obtained.
Figure 2
Figure 2. Twist repression of E-cadherin promoter
A, Dose dependent repression of E-cadherin promoter. Determination of the degree of suppression of the full-length E-cadherin promoter activity in the presence of increasing amounts of Twist plasmid in transient co-transfection assays. The Y103X mutant Twist construct (Mut) was used to test for specificity of repression. B, Upper panel shows a schematic of the E-cadherin promoter with E boxes shown as hollow triangles. Deletion constructs are indicated at 5′ end with E1–E7. Twist represses E-cadherin transcriptionally. Each of the 6 E-cadherin promoter reporter constructs was repressed 1.2 to 2 fold by Twist. The largest significant repression was seen in construct E4, indicating the importance of the proximal region in E-cadherin regulation by Twist. Statistical significance (P<0.05) is indicated by asterisks. C, Full length Twist is essential for E-cadherin repression. Upper panel shows E-cadherin E4 construct with E-box mutants indicated by M1, M2, and M3. Twist repression was statistically significant only in M1 construct indicating its lack of function in mediating the repression. This indicates that E-box 2 and 3 may play an important role in the down-regulation of E-cadherin by Twist. D, Upper panel shows Twist deletion mutants. Mutations are indicated with amino acids changed to stop codons. Lower panel shows mutant Twist constructs were unable to repress E-cadherin promoter significantly indicating that regions other than the basic helix loop helix domain play a role in the repression of E-cadherin.
Figure 3
Figure 3. In vivo binding of Twist protein to the E-cadherin promoter sequence
ChIP was carried out following established protocols using MCF-7/Twist and Hs578 T cells and analyzed using E-cadherin promoter-specific primers by PCR. Primers amplified a 93 base pair fragment. Identical volumes from the final precipitate were used for the PCR reactions. M-molecular weight marker (bp), lane 1- total input immunoprecipitate, lane 2- acetylated histone H3 immunoprecipitate, lane 3- no chromatin immunoprecipitate, lane 4- no antibody immunoprecipitate and lane 5- Twist immunoprecipitate.
Figure 4
Figure 4. Relation between Twist and E-cadherin expression in patient breast cancer samples
A, mRNA levels of Twist and E-cadherin in breast tumors measured by quantitative real-time PCR. A total of 31 breast tumor (grade I=6, grade II=12, grade III=13) and four normal breast samples were analyzed. Loss of E-cadherin expression was concomitant with increased Twist expression in higher-grade tumors. B, A trend towards an inverse correlation was observed between Twist and E-cadherin expression (r=−0.27, p=0.14) in the breast cancer patient samples. C, Results of immunohistochemical analysis of Twist and E-cadherin expression in eighty-seven human breast cancer samples. The crosstab shows comparison of Twist nuclear staining and its intensity (classified as low vs. medium/high) against E-cadherin expression (absent/low/medium vs. high). D, Representative photomicrographs of human breast tumor samples from lobular and ductal samples that were analyzed for Twist and E-cadherin levels (left panel − 40×, middle and right panel −20×).
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Jan Y, Jan L. Functional Gene Cassettes in Development. PNAS. 1993;90:8305–8307. - PMC - PubMed
    1. Murre C, McCaw PS, Baltimore D. A new DNA binding and dimerization motif in immunoglobulin enhancer binding, daughterless, MyoD, and myc proteins. Cell. 1989;56:777–83. - PubMed
    1. Thisse B, el Messal M, Perrin-Schmitt F. The twist gene: isolation of a Drosophila zygotic gene necessary for the establishment of dorsoventral pattern. Nucleic Acids Res. 1987;15:3439–53. - PMC - PubMed
    1. Chen ZF, Behringer RR. twist is required in head mesenchyme for cranial neural tube morphogenesis. Genes Dev. 1995;9:686–99. - PubMed
    1. Wang SM, Coljee VW, Pignolo RJ, Rotenberg MO, Cristofalo VJ, Sierra F. Cloning of the human twist gene: its expression is retained in adult mesodermally-derived tissues. Gene. 1997;187:83–92. - PubMed

Publication types

MeSH terms